Fosun Pharma: Repurchased 1.3 Million Shares on September 15

Fosun Pharma announced that on September 15, 2026, the company repurchased 1.3 million shares on the Hong Kong Stock Exchange at a price range of HK$16.89 to HK$17.1 per share, for a total repurchase amount of HK$22.0707 million. The repurchased shares are intended to be held as treasury shares. Prior to this repurchase, the company had 536 million issued shares, and the repurchased shares accounted for 0.24%. The company's repurchase mandate was approved on June 16, 2026, authorizing a total of 54.0972 million shares to be repurchased. To date, a cumulative 6.159 million shares have been repurchased, representing 1.14% of the issued shares as of the date the mandate was approved. Following this repurchase, there will be a 30-day moratorium on new share issuance and the sale or transfer of treasury shares, until October 15, 2026.